Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
Getting the Brand Back Together: A Year in Trademarks
Getting the Brand Back Together: A Year in Trademarks
January 07, 2022
1min
Halo’s Effect on Opinion of Counsel Defenses
Halo’s Effect on Opinion of Counsel Defenses
December 06, 2021
1min
The New “Cancel Culture” at the USPTO
The New “Cancel Culture” at the USPTO
November 23, 2021
3min
Events
When NFTs Go to Market: Preventing Fraud and Theft of Digital Currency
When NFTs Go to Market: Preventing Fraud and Theft of Digital Currency
Thursday, January 27, 2022 Venable LLP
Recent News
Joshua Rosenberg Joins Venable’s Litigation Practice in Los Angeles
Joshua Rosenberg Joins Venable’s Litigation Practice in Los Angeles
January 18, 2022
2min
Venable Adds Seven-Member Healthcare Policy Team to Its Washington, DC Legislative and Government Affairs Group
Venable Adds Seven-Member Healthcare Policy Team to Its Washington, DC Legislative and Government Affairs Group
January 18, 2022
4min
DesignIntelligence Features Jim Burnley and Jim Reilly on DeMystifying the Infrastructure Bill Podcast Series
DesignIntelligence Features Jim Burnley and Jim Reilly on DeMystifying the Infrastructure Bill Podcast Series
January 12, 2022
1min